Bridgeway Capital Management, LLC Harvard Bioscience Inc Transaction History

Bridgeway Capital Management, LLC

$4.44 Billion
Q3 2024

A detailed history of Bridgeway Capital Management, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 184,500 shares of HBIO stock, worth $394,830. This represents 0.01% of its overall portfolio holdings.

Number of Shares

184,500

Previous 184,500 -0.0%

Holding current value

$394,830

Previous $525,000 5.52%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$4.02 - $5.39 $55,877 - $74,921	-13,900 Reduced 7.01%	184,500 $782,000
Q1 2023 May 15, 2023	SELL	$2.45 - $4.22 $61,250 - $105,500	-25,000 Reduced 11.19%	198,400 $833,000
Q4 2022 Feb 14, 2023	SELL	$2.12 - $2.86 $105,152 - $141,856	-49,600 Reduced 18.17%	223,400 $618,000
Q3 2022 Nov 14, 2022	SELL	$2.33 - $3.92 $24,698 - $41,552	-10,600 Reduced 3.74%	273,000 $699,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.42 $190,512 - $372,892	58,083 Added 25.76%	283,600 $1.02 Million
Q1 2022 May 16, 2022	SELL	$5.16 - $7.14 $895,776 - $1.24 Million	-173,600 Reduced 43.5%	225,517 $1.4 Million
Q4 2021 Feb 14, 2022	SELL	$6.37 - $8.18 $191,100 - $245,400	-30,000 Reduced 6.99%	399,117 $2.81 Million
Q2 2021 Aug 16, 2021	BUY	$5.44 - $8.4 $485,248 - $749,280	89,200 Added 26.24%	429,117 $3.58 Million
Q1 2021 May 17, 2021	SELL	$3.91 - $6.99 $264,316 - $472,524	-67,600 Reduced 16.59%	339,917 $1.86 Million
Q4 2020 Feb 16, 2021	SELL	$3.0 - $4.5 $442,500 - $663,750	-147,500 Reduced 26.58%	407,517 $1.75 Million
Q3 2020 Nov 16, 2020	SELL	$2.75 - $4.2 $206,250 - $315,000	-75,000 Reduced 11.9%	555,017 $1.67 Million
Q2 2020 Aug 14, 2020	BUY	$2.12 - $3.14 $8,056 - $11,932	3,800 Added 0.61%	630,017 $1.95 Million
Q1 2020 May 15, 2020	SELL	$1.42 - $3.29 $27,548 - $63,826	-19,400 Reduced 3.0%	626,217 $1.38 Million
Q3 2019 Nov 14, 2019	BUY	$1.59 - $3.47 $165,837 - $361,921	104,300 Added 19.27%	645,617 $1.99 Million
Q2 2019 Aug 14, 2019	SELL	$1.93 - $4.59 $121,976 - $290,088	-63,200 Reduced 10.45%	541,317 $1.08 Million
Q1 2019 May 15, 2019	SELL	$2.77 - $4.38 $96,673 - $152,862	-34,900 Reduced 5.46%	604,517 $2.61 Million
Q4 2018 Feb 14, 2019	BUY	$3.03 - $5.0 $61,205 - $101,000	20,200 Added 3.26%	639,417 $2.03 Million
Q3 2018 Nov 13, 2018	SELL	$5.0 - $6.65 $753,500 - $1 Million	-150,700 Reduced 19.57%	619,217 $3.25 Million
Q1 2018 May 15, 2018	SELL	$3.3 - $5.15 $217,800 - $339,900	-66,000 Reduced 7.9%	769,917 $3.85 Million
Q4 2017 Feb 14, 2018	BUY	$3.08 - $3.8 $154,924 - $191,140	50,300 Added 6.4%	835,917 $2.76 Million
Q3 2017 Nov 14, 2017	BUY	$2.7 - $3.75 $2.12 Million - $2.95 Million	785,617	785,617 $2.95 Million

Others Institutions Holding HBIO

# of Institutions

Shares Held

30.6M

Call Options Held

700

Put Options Held

2.1K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Account

Bridgeway Capital Management, LLC Harvard Bioscience Inc Transaction History